about
CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-BLymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forcesThe pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemiaDifferential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia.Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.Molecular and cellular mechanisms of CLL: novel therapeutic approaches.Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signalingChemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?Canonical and noncanonical Hedgehog/GLI signaling in hematological malignancies.CD44: More than a mere stem cell marker.Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells.CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanismsSmall peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer.Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.B-cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T-cell clonality in chronic lymphocytic leukemia.Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemiaCombined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells.KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway.The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.Over-expression of bacterial gamma-glutamylcysteine synthetase (GSH1) in plastids affects photosynthesis, growth and sulphur metabolism in poplar (Populus tremula x Populus alba) dependent on the resulting gamma-glutamylcysteine and glutathione leveIbrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter.Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells.Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.
P50
Q22001506-74A76F30-61DE-4D30-87E8-ADB1308C6EC4Q28115946-FAC63CE6-138C-4888-B008-E012895974BDQ33655756-AED7BF00-F4D7-45A1-B2B1-FBA0E01D6EF7Q34005556-FEE50B71-14C2-471E-9469-6FDC05DA72BCQ34432943-20293EDA-F8F2-415A-BA12-AD003330E460Q34533552-AEA20C95-7D68-4D09-804E-12F13173CCBFQ35489417-E5BAFF0A-A69C-467C-AF19-8EA382B158F7Q35602348-2521629F-3CD6-491D-AF46-61D3C8D643C6Q36018118-D595BE9C-BC90-4CB5-8F75-D84B74EFF373Q37504699-6D0DCFA7-ED08-47BC-A410-DEECF8543A31Q37593573-21C5DDA0-4E03-459D-87B2-A4A07C9DE52AQ37603281-2657C54C-B559-4057-BC38-D8456640FC9DQ37607838-6B3DC466-0341-49B5-BE98-2C0CE5D96901Q37983913-C16952D3-0AB1-472C-91F6-50270DE0C5B6Q37990679-19DE5550-151B-430A-909C-751522D53368Q38957873-94BEBF6B-C63A-4B65-BBEE-CBB22A58C312Q39658557-EB99198D-12D6-43E7-A1F9-E3E5BE75D515Q39684126-11539B8C-9268-42AC-A65D-702173595F17Q39865621-5D9A22C3-F16E-4889-B146-FFFE7099A58BQ40420056-CCF88F2D-6D29-4302-A08E-13237A4A76A2Q40439589-90999A55-7565-46C1-A0BC-07C52C2F1CBFQ40469303-40180679-37F3-4E2A-B30B-027FF7D9341EQ40808021-47515D85-90FC-48A8-AAF8-942E7D9A4FACQ40928223-6B81FB09-F643-41AC-BBBB-A094045443FDQ42217233-4F404A44-75A5-41DB-9F03-3BDC25EA1D86Q42277237-30C412D9-3C4D-4CE5-BC45-FF026C256547Q42330187-BDFF56BC-4784-4433-A5B4-DD94B8D239B7Q42399857-0FC93BA5-5929-4C59-A1D6-44B8D1F04610Q42551543-5AF6547B-EF21-4686-9B0B-38738F7F4BA0Q42742466-BDE40C07-FF5E-438C-B62F-239CF8681569Q42807114-F80C1002-2AA1-41C0-8C0A-8438847F3FC8Q42818551-D709ACF9-B181-41DF-9C2A-1BF56B01227FQ42880733-A9D50B91-975B-4148-A79D-BD6FC05E4BEAQ43144014-5609DC83-3889-4194-8A64-2DFB8B24A6F1Q44558291-DD94302A-CC6A-45EB-BEBA-77B3D23D0818Q44645796-2EFC7E90-64E2-4CAB-A0E1-61C314BE5A41Q45782254-4E2799C9-C45F-49B5-85FB-187ACA1D1075Q46085197-A18AEAAE-DC4B-491E-B490-F9DB3FFEB090Q46463597-4A62FA3A-9A9D-4241-AAC8-BA53653912F9Q49912101-586579A6-9B50-43C4-9C7F-35386D5AAA1D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tanja Hartmann
@fr
Tanja N Hartmann
@en
Tanja N Hartmann
@es
Tanja N Hartmann
@nl
Tanja N Hartmann
@sl
type
label
Tanja Hartmann
@fr
Tanja N Hartmann
@en
Tanja N Hartmann
@es
Tanja N Hartmann
@nl
Tanja N Hartmann
@sl
prefLabel
Tanja Hartmann
@fr
Tanja N Hartmann
@en
Tanja N Hartmann
@es
Tanja N Hartmann
@nl
Tanja N Hartmann
@sl
P1053
C-9345-2017
P106
P21
P31
P496
0000-0002-2633-7301